Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26:1343–421.

Article  PubMed  Google Scholar 

Zimmermann MB, Boelaert K. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 2015;3:286–95.

Article  CAS  PubMed  Google Scholar 

Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993;22:263–77.

Article  CAS  PubMed  Google Scholar 

Hall P, Lundell G, Holm LE. Mortality in patients treated for hyperthyroidism with iodine-131. Acta Endocrinol (Copenh). 1993;128:230–4.

CAS  PubMed  Google Scholar 

Klein I, Becker DV, Levey GS. Treatment of hyperthyroid disease. Ann Intern Med. 1994;121:281–8.

Article  CAS  PubMed  Google Scholar 

Smith TJ, Hegedus L. Graves’ Disease. N Engl J Med. 2016;375:1552–65.

Article  PubMed  Google Scholar 

Antonelli A, Fallahi P, Elia G, Ragusa F, Paparo SR, Ruffilli I, et al. Graves’ disease: clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapy. Best Pract Res Clin Endocrinol Metab. 2020;34:101388.

Article  CAS  PubMed  Google Scholar 

Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr. 2008;88:S491–9.

Article  Google Scholar 

Deluca HF. History of the discovery of vitamin D and its active metabolites. Bonekey Rep. 2014;3:479.

Article  PubMed  PubMed Central  Google Scholar 

Gallo D, Piantanida E, Badino P, Mortara L. The story of a vitamin for bone health that upgraded to hormone for systemic good health.

Gallo D, Mortara L, Gariboldi MB, Cattaneo S, a. M, Rosetti S, Gentile L, et al. Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review. J Endocrinol Invest. 2020;43:413–29.

Article  CAS  PubMed  Google Scholar 

Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J Immunol. 2005;175:5–14.

Kim D. The role of vitamin D in thyroid diseases. Int J Mol Sci. 2017;18:1949.

Article  PubMed  PubMed Central  Google Scholar 

Rapoport B, McLachlan SM. Graves’ hyperthyroidism is antibody-mediated but is predominantly a Th1-Type cytokine disease. J Clin Endocrinol Metabolism. 2014;99:4060–1.

Article  CAS  Google Scholar 

Rapoport B, McLachlan SM. Reflections on thyroid autoimmunity: a personal overview from the past into the future. Horm Metab Res. 2018;50:840–52.

Article  CAS  PubMed  Google Scholar 

Plazinska MT, Czarnywojtek A, Sawicka-Gutaj N, Zgorzalewicz-Stachowiak M, Czarnocka B, Gut P, et al. Vitamin D deficiency and thyroid autoantibody fluctuations in patients with Graves’ disease - A mere coincidence or a real relationship? Adv Med Sci. 2020;65:39–45.

Article  CAS  PubMed  Google Scholar 

Muscogiuri G, Tirabassi G, Bizzaro G, Orio F, Paschou SA, Vryonidou A, et al. Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr. 2015;69:291–6.

Article  CAS  PubMed  Google Scholar 

D’Aurizio F, Villalta D, Metus P, Doretto P, Tozzoli R. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev. 2015;14:363–9.

Article  PubMed  Google Scholar 

Effraimidis G, Badenhoop K, Tijssen JG, Wiersinga WM. Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur J Endocrinol. 2012;167:43–8.

Article  CAS  PubMed  Google Scholar 

Wang J, Lv S, Chen G, Gao C, He J, Zhong H, et al. Meta-analysis of the Association between Vitamin D and autoimmune thyroid disease. Nutrients. 2015;7:2485–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu M-Y, Cao B, Yin J, Wang D-F, Chen K-L, Lu Q-B. Vitamin D and Graves’ disease: a meta-analysis update. Nutrients. 2015;7:3813–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fahmy O, Fahmy UA, Alhakamy NA, Khairul-Asri MG. Single-Port versus multiple-Port Robot-assisted radical prostatectomy: a systematic review and Meta-analysis. J Clin Med. 2021;10:5723.

Article  PubMed  PubMed Central  Google Scholar 

Taheriniya S, Arab A, Hadi A, Fadel A, Askari G. Vitamin D and thyroid disorders: a systematic review and Meta-analysis of observational studies. BMC Endocr Disord. 2021;21:171.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng Y, Qiu T, Chen H, Wei Y, Jiang X, Zhang H, et al. Association of serum IL-21 and vitamin D concentrations in Chinese children with autoimmune thyroid disease. Clin Chim Acta. 2020;507:194–8.

Article  CAS  PubMed  Google Scholar 

Heisel CJ, Riddering AL, Andrews CA, Kahana A. Serum vitamin D Deficiency is an independent risk factor for thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. 2020;36:17–20.

Article  PubMed  Google Scholar 

Mangaraj S, Choudhury A, Swain B, Sarangi P, Mohanty B, Baliarsinha A. Evaluation of vitamin D status and its impact on thyroid related parameters in new onset Graves’ disease- A cross-sectional observational study. Indian J Endocr Metab. 2019;23:35.

Article  CAS  Google Scholar 

Planck T, Shahida B, Malm J, Manjer J. Vitamin D in Graves Disease: levels, correlation with Laboratory and Clinical parameters, and Genetics. Eur Thyroid J. 2018;7:27–33.

Article  CAS  PubMed  Google Scholar 

Ke W, Sun T, Zhang Y, He L, Wu Q, Liu J, et al. 25-Hydroxyvitamin D serum level in Hashimoto’s thyroiditis, but not Graves’ disease is relatively deficient. Endocr J. 2017;64:581–7

Li X, Wang G, Lu Z, Chen M, Tan J, Fang X. Serum 25-hydroxyvitamin D predict prognosis in radioiodine therapy of Graves’ disease. J Endocrinol Invest. 2015;38:753–9.

Article  CAS  PubMed  Google Scholar 

Ma J, Wu D, Li C, Fan C, Chao N, Liu J, et al. Lower serum 25-Hydroxyvitamin D level is Associated with 3 types of autoimmune thyroid diseases. Medicine. 2015;94:e1639.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Liang L, Xie Z. Low vitamin D status is Associated with increased thyrotropin-receptor antibody titer in Graves Disease. Endocr Pract. 2015;21:258–63.

Article  PubMed  Google Scholar 

Yasuda T, Okamoto Y, Hamada N, Miyashita K, Takahara M, Sakamoto F, et al. Serum vitamin D levels are decreased in patients without remission of Graves’ disease. Endocrine. 2013;43:230–2.

Article  CAS  PubMed  Google Scholar 

Jyotsna VP, Sahoo A, Ksh SA, Sreenivas V, Gupta N. Bone mineral density in patients of Graves disease pre- & post-treatment in a predominantly vitamin D deficient population. Indian J Med Res. 2012;135:36–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Czernobilsky H, Scharla S, Schmidt-Gayk H, Ziegler R. Enhanced suppression of 1,25(OH)2D3 and intact parathyroid hormone in Graves’ disease as compared to toxic nodular goiter. Calcif Tissue Int. 1988;42:5–12.

Article  CAS  PubMed